Omicron BA.1, BA.2 and COVID-19 Booster Vaccination

被引：4
作者：
Assawakosri, Suvichada [1 ,2 ]
Kanokudom, Sitthichai [1 ,2 ]
Suntronwong, Nungruthai [1 ]
Puenpa, Jiratchaya [1 ]
Duangchinda, Thaneeya [3 ]
Chantima, Warangkana [4 ,5 ]
Pakchotanon, Pattarakul [3 ]
Mongkolsapaya, Juthathip [6 ,7 ]
Wanlapakorn, Nasamon [1 ]
Honsawek, Sittisak [2 ]
Poovorawan, Yong [1 ,8 ]
机构：
[1] Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand
[2] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Osteoarthrit & Musculoskeleton Res Unit, King Chulalongkorn Mem Hosp,Thai Red Cross Soc, Bangkok, Thailand
[3] Natl Sci & Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Mol Biol Dengue & Flaviviruses Res Team, Pathum Thani, Thailand
[4] Mahidol Univ, Siriraj Hosp, Div Dengue Hemorrhag Fever Res, Fac Med, Bangkok, Thailand
[5] Mahidol Univ, Siriraj Hosp, Siriraj Ctr Res Excellence Dengue & Emerging Path, Fac Med, Bangkok, Thailand
[6] Univ Oxford, Nuffield Dept Med, Wellcome Ctr Human Genet, Oxford, England
[7] Univ Oxford, Chinese Acad Med Sci, Oxford Inst, Oxford, England
[8] Royal Soc Thailand, Royal Soc Thailand FRS T, Bangkok, Thailand
来源：
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 226卷 / 08期
关键词：
D O I：
10.1093/infdis/jiac158
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1480 / 1481
页数：2
相关论文
共 50 条
  • [21] Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
    Yu, Jingyou
    Collier, Ai-ris Y.
    Rowe, Marjorie
    Mardas, Fatima
    Ventura, John D.
    Wan, Huahua
    Miller, Jessica
    Powers, Olivia
    Chung, Benjamin
    Siamatu, Mazuba
    Hachmann, Nicole P.
    Surve, Nehalee
    Nampanya, Felix
    Chandrashekar, Abishek
    Barouch, Dan H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16)
  • [22] Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5
    Diem, Gabriel
    Jaeger, Michael
    Dichtl, Stefanie
    Bauer, Angelika
    Lass-Floerl, Cornelia
    Reindl, Markus
    Wilflingseder, Doris
    Posch, Wilfried
    MICROBIOLOGY SPECTRUM, 2023, 11 (03):
  • [23] Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination
    Assawakosri, Suvichada
    Kanokudom, Sitthichai
    Chansaenroj, Jira
    Suntronwong, Nungruthai
    Auphimai, Chompoonut
    Nilyanimit, Pornjarim
    Vichaiwattana, Preeyaporn
    Thongmee, Thanunrat
    Duangchinda, Thaneeya
    Chantima, Warangkana
    Pakchotanon, Pattarakul
    Srimuan, Donchida
    Thatsanatorn, Thaksaporn
    Klinfueng, Sirapa
    Sudhinaraset, Natthinee
    Mongkolsapaya, Juthathip
    Wanlapakorn, Nasamon
    Honsawek, Sittisak
    Poovorawan, Yong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 793 - 801
  • [24] SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2
    de Michelena, Paula
    Olea, Beatriz
    Torres, Ignacio
    Gonzalez-Candelas, Fernando
    Navarro, David
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (12) : 5836 - 5840
  • [25] Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
    Vasin, Andrey V.
    Stukova, Marina A.
    LANCET INFECTIOUS DISEASES, 2023, 23 (08) : 880 - 881
  • [26] BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
    Annika Rössler
    Antonia Netzl
    Ludwig Knabl
    Helena Schäfer
    Samuel H. Wilks
    David Bante
    Barbara Falkensammer
    Wegene Borena
    Dorothee von Laer
    Derek J. Smith
    Janine Kimpel
    Nature Communications, 13
  • [27] Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3-4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination
    Assawakosri, Suvichada
    Kanokudom, Sitthichai
    Suntronwong, Nungruthai
    Chansaenroj, Jira
    Auphimai, Chompoonut
    Nilyanimit, Pornjarim
    Vichaiwattana, Preeyaporn
    Thongmee, Thanunrat
    Duangchinda, Thaneeya
    Chantima, Warangkana
    Pakchotanon, Pattarakul
    Srimuan, Donchida
    Thatsanathorn, Thaksaporn
    Klinfueng, Sirapa
    Sudhinaraset, Natthinee
    Wanlapakorn, Nasamon
    Mongkolsapaya, Juthathip
    Honsawek, Sittisak
    Poovorawan, Yong
    HELIYON, 2024, 10 (01)
  • [28] BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
    Roessler, Annika
    Netzl, Antonia
    Knabl, Ludwig
    Schaefer, Helena
    Wilks, Samuel H.
    Bante, David
    Falkensammer, Barbara
    Borena, Wegene
    von Laer, Dorothee
    Smith, Derek J.
    Kimpel, Janine
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [29] Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
    Kawasuji, Hitoshi
    Morinaga, Yoshitomo
    Tani, Hideki
    Saga, Yumiko
    Yamada, Hiroshi
    Yoshida, Yoshihiro
    Takegoshi, Yusuke
    Kaneda, Makito
    Murai, Yushi
    Kimoto, Kou
    Ueno, Akitoshi
    Miyajima, Yuki
    Nagaoka, Kentaro
    Ono, Chikako
    Matsuura, Yoshiharu
    Niimi, Hideki
    Yamamoto, Yoshihiro
    MICROBIOLOGY SPECTRUM, 2023, 11 (02):
  • [30] Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections
    Qassim, Suelen H.
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    AlMukdad, Sawsan
    Tang, Patrick
    Hasan, Mohammad R.
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Smatti, Maria K.
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed Ghaith
    Al-Khal, Abdullatif
    Coyle, Peter
    Kaleeckal, Anvar Hassan
    Shaik, Riyazuddin Mohammad
    Latif, Ali Nizar
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Butt, Adeel A.
    Bertollini, Roberto
    Al-Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Abu-Raddad, Laith J.
    JOURNAL OF TRAVEL MEDICINE, 2022, 29 (06)
12345